摘要
在梳理近年国内外降脂中药研究成果的基础上,分别从降脂中药体外筛选模型、有效单体、复方和单味降脂中药以及降脂中成药等几个方面详细阐述降脂中药的研究现状,提出降脂中药有效单体的开发利用和中药有效单体组分配伍的思路,强调通过借用中药筛选细胞模型发现新的降脂中药单体和降脂机制,突破以临床经验积累作为研制新药的单一模式,针对单味药固定组分的改变、不同药物有效组分配伍的加减、不同病理环节的组分配伍和有效单体性味归经等展开研究,加快中药有效单体配伍理论的创新,使中药配伍研究从饮片层次上升到组分层次,使中药药理的作用靶点、作用环节及作用机制更加清楚,促进中药新药研究及临床疗效的提高和中医药理论的创新。
According to research results of the lipid -lowering Chinese medicine at home and abroad in recent years, the paper will elaborate on the research status of the antihyperlipidemia effects of chinese medicine from the aspects of its vitro screening model, effective monomer, compounding, single medicine and antihyperlipidemia traditional Chinese medicine patent prescription. Put the ideas of development and use on the antihyperlipidemia effects of chinese medicine effective monomer and components medicine compatibility, emphasize on through new medicine screening cell model to find the antihyperlipidemia effects of chinese medicine monomer and antihyperlipidemia mechanism, breakthrough the single mode to use the accumulate of experience in clinical research as the development of new drugs. Study against the changes of the single-ingredient fixed component, the modify of the effective components combination of different drugs, the component compatibility of the different pathological link and the properties of the effective monomer, accelerate the theoretical innovation about the combination of effective medicine monomer, improve the research levels of the medicine combination from pieces to component, make the action target, link, and mechanism of herbal pharmacology more clear, promote the new Chinese herbal research, the improvement of the clinical efficient and the theory innovation of traditional chinese medicine.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2007年第11期1005-1008,共4页
China Journal of Chinese Materia Medica
关键词
降脂中药
理论研究
antihyperlipidemia
Chinese medicine
theoretical research